PR Prolongation as a Predictor of Atrial Fibrillation Onset: A State-of-the-Art Review.

Atrial Fibrillation First Degree AV Block PR interval PR prolongation

Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
16 Feb 2024
Historique:
received: 13 02 2024
accepted: 15 02 2024
medline: 19 2 2024
pubmed: 19 2 2024
entrez: 18 2 2024
Statut: aheadofprint

Résumé

First-degree atrioventricular block (1-AVB), characterized by a PR interval exceeding 200 milliseconds, has traditionally been perceived as a benign cardiac condition. Recently, this perception has been challenged by investigations that indicate a potential association between PR prolongation and an elevated risk of atrial fibrillation (AF). To consolidate these findings, we performed a comprehensive review to assess the available evidence indicating a relationship between these two conditions. We searched MEDLINE and EMBASE databases as well as manually searched references of retrieved articles. We selected 18 cohort studies/meta-analyses involving general and special populations. Consistent findings across expansive cohort studies reveal that incremental increases in the PR interval may serve as an independent risk factor for AF. However, our analyses underscore the need for further research into the association between 1-AVB, defined by a specified PR interval cutoff, and the risk of AF.

Identifiants

pubmed: 38369207
pii: S0146-2806(24)00108-7
doi: 10.1016/j.cpcardiol.2024.102469
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102469

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Zain S Ali (ZS)

Faculty of Health Sciences, School of Medicine, Queen's University, Kingston, Ontario, Canada.

Abdullah Bhuiyan (A)

Faculty of Health Sciences, School of Medicine, Queen's University, Kingston, Ontario, Canada.

Purav Vyas (P)

Faculty of Health Sciences, School of Medicine, Queen's University, Kingston, Ontario, Canada.

Andres F Miranda-Arboleda (AF)

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Gary Tse (G)

Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

George Bazoukis (G)

Department of Cardiology, Larnaca General Hospital, Larnaca, Cyprus; European University Cyprus, School of Medicine, Nicosia, Cyprus.

Cengiz Burak (C)

Department of Medicine, Kingston Health Sciences Center, Queen's University, Kingston, Ontario, Canada.

Wael Abuzeid (W)

Department of Medicine, Kingston Health Sciences Center, Queen's University, Kingston, Ontario, Canada.

Sharen Lee (S)

Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

Shyla Gupta (S)

Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Mohammad Amin M Eshfahani (MAM)

Faculty of Health Sciences, School of Medicine, Queen's University, Kingston, Ontario, Canada.

Adrian Baranchuk (A)

Department of Medicine, Kingston Health Sciences Center, Queen's University, Kingston, Ontario, Canada. Electronic address: barancha@kgh.kari.net.

Classifications MeSH